Listen to our interview with Prof. van As explaining the PACE-A Trial data.
Prof. van As presented the primary endpoint analysis from PACE-A Trial during ASCO GU Cancers Symposium.
The inauguration ceremony of the newest CyberKnife® facility at the Pakistan Atomic Energy Commission’s flagship cancer-care hospital.
2022 was a busy year for the Accuray Exchange webinar program.
Today is the 20th anniversary of the first CyberKnife® System in Europe.
It is that time of the year again – the abstract outcomes for ESTRO 2023 have been sent.
TG-306, the new AAPM task group protocol for QA of TomoTherapy®, was recently accepted for publication.
A new special issue of the American Journal of Clinical Oncology reports on the proceedings of a breast cancer radiotherapy summit held in Florence, Italy this past summer.
Season’s greetings, Accuray Exchange (AEx) members
The 10th Chinese national CyberKnife® oncology radiotherapy annual meeting was successfully held on November 26th, 2022.
© 2023 Accuray Incorporated